Ondrej Vlcek, a director at $GEN, sold 47,462 shares of the company on 08-21-2026 for an estimated $1,376,407. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.3% of their shares of this class of stock. Following this trade, they now own 3,685,262 shares of this class of $GEN stock.
$GEN Insider Trading Activity
$GEN insiders have traded $GEN stock on the open market 5 times in the past 6 months. Of those trades, 1 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $GEN stock by insiders over the last 6 months:
- ONDREJ VLCEK has made 0 purchases and 3 sales selling 247,462 shares for an estimated $6,654,707.
- JOHN C CHRYSTAL purchased 3,000 shares for an estimated $81,171
- TRAVIS MICHAEL WITTEVEEN (Head of Products and Portfolio) sold 440 shares for an estimated $12,346
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$GEN Hedge Fund Activity
We have seen 377 institutional investors add shares of $GEN stock to their portfolio, and 373 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- STARBOARD VALUE LP removed 7,806,922 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $194,314,288
- AMERIPRISE FINANCIAL INC added 7,775,848 shares (+39.0%) to their portfolio in Q2 2026, for an estimated $193,540,856
- BOSTON PARTNERS added 5,782,014 shares (+38.8%) to their portfolio in Q2 2026, for an estimated $143,914,328
- ALYESKA INVESTMENT GROUP, L.P. removed 5,775,514 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $143,752,543
- NORGES BANK added 5,221,810 shares (+443.8%) to their portfolio in Q2 2026, for an estimated $129,970,850
- BEUTEL, GOODMAN & CO LTD. removed 4,641,980 shares (-44.7%) from their portfolio in Q2 2026, for an estimated $115,538,882
- PICTET ASSET MANAGEMENT HOLDING SA removed 4,219,148 shares (-80.0%) from their portfolio in Q2 2026, for an estimated $105,014,593
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$GEN Revenue
$GEN had revenues of $1.3B in Q1 2027. This is an increase of 6.28% from the same period in the prior year.
You can track GEN financials on Quiver Quantitative's GEN stock page.
You can access data on GEN stock through the Quiver Quantitative API.
$GEN Congressional Stock Trading
Members of Congress have traded $GEN stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $GEN stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 04/14.
- SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$GEN Price Targets
Multiple analysts have issued price targets for $GEN recently. We have seen 4 analysts offer price targets for $GEN in the last 6 months, with a median target of $25.5.
Here are some recent targets:
- Robert Coolbrith from Evercore ISI Group set a target price of $38.0 on 05/08/2026
- Saket Kalia from Barclays set a target price of $27.0 on 05/08/2026
- Matthew Hedberg from RBC Capital set a target price of $24.0 on 05/08/2026
- Richard Poland from Wells Fargo set a target price of $22.0 on 03/03/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
